tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Stock WebsitesTop Gainers/ Losers/ Active StocksDividend StocksChatGPT Stocks
ETFs
ETF CenterTop ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Crypto CenterBitcoin
Popular
Ethereum
Research Tools
Stock ScreenerETF Screener
Popular
Compare StocksCompare ETFsTrending StocksPenny Stock ScreenerDaily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit CalculatorCompound Interest Calculator
New
Mortgage Calculator
New
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Stock Websites
Top Gainers/ Losers/ Active Stocks
Dividend Stocks
ChatGPT Stocks
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Research Tools
Stock Screener
ETF Screener
Popular
Compare Stocks
Compare ETFs
Trending Stocks
Penny Stock Screener
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compound Interest Calculator
New
Mortgage Calculator
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Enterprise Solutions
Plans & Pricing
Education
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us
TipRanksTop Financial ExpertsInsidersAnderson Kenneth Carl

Anderson Kenneth Carl Insider Profile

4 Followers
Anderson Kenneth Carl, Director at C4 Therapeutics, holds 306.34K shares in C4 Therapeutics (Ticker: CCCC).
See the Hottest Stocks Based on Insider Trading >
tipranks
Anderson Kenneth Carl

Anderson Kenneth Carl
C4 Therapeutics (CCCC)
Director

Ranked #102,076 out of 105,137 Corporate Insiders

Profitable Transactions

0%
0 out of 5 Profitable Transactions

Average Return

-68.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
How are Insiders Ranked?

Insider Holdings

$625K
100.00%
A breakdown of Anderson Kenneth Carl's holdings
See the Top Stocks by Insiders

Insider Roles

C4 Therapeutics
(CCCC)
Director
Roles that Anderson Kenneth Carl holds in companies
See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:
C4 Therapeutics
(CCCC)
Rating:Informative Buy
Date:Jul 18, 2022 - Jul 18, 2023
Return:-62.10%
The most profitable trade made by Anderson Kenneth Carl
See the Latest Stocks Traded by Insiders

Anderson Kenneth Carl's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
CCCC
C4 Therapeutics
Jul 05, 2023
Director
Uninformative Buy
11.25K
$624.94K
Success Rate for CCCC
0 out of 5 profitable transactions on CCCC
0%
Average Return for CCCC
Average return per transaction on CCCC
-68.54%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Oct 06, 2020
Uninformative Buy
$0.00
-
$0.00
―
Apr 06, 2021
Uninformative Buy
$8.74K
-
$37.51
―
Apr 14, 2021
Informative Buy
$2.77K
-
$3.90
-73.00%
Apr 14, 2021
Uninformative Buy
$0.00
-
$0.00
―
Jul 07, 2021
Uninformative Buy
$8.74K
-
$39.72
―
List of latest transactions for each holding click on a transaction to see Anderson Kenneth Carl's performance on stock
See All Insider Trading from Today

You May Also Like

Meet our Smart Portfolio. See what top analysts say about your stocks.Get a breakdown of the different strategies based on detected insider trading activity.Find the best performing Analyst in each sector. Follow them so you never miss a recommendation.

Anderson Kenneth Carl insider profile FAQ

What is the percentage of profitable transactions made by Anderson Kenneth Carl?
The percentage of profitable transactions made by Anderson Kenneth Carl is 0%.
    What is the average return per transaction made by Anderson Kenneth Carl?
    The average return per transaction made by Anderson Kenneth Carl is -68.50%.
      What stocks does Anderson Kenneth Carl hold?
      Anderson Kenneth Carl holds: CCCC stocks.
        What was Anderson Kenneth Carl’s latest transaction?
        Anderson Kenneth Carl latest transaction was an Uninformative Buy of $11.25K.
          What was Anderson Kenneth Carl's most profitable transaction?
          Anderson Kenneth Carl’s most profitable transaction was an Informative Buy of CCCC stock on July 18, 2022. The return on the trade was -62.10%.
            What is Anderson Kenneth Carl's role in C4 Therapeutics?
            Anderson Kenneth Carl's role in C4 Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.